Kinney Drugs Foundation has announced a $250,000 pledge to the Crouse Health Foundation’s CrouseCares Campaign in support of the renovation and expansion of the Baker Regional Neonatal Intensive Care Unit (NICU) at Crouse Health. “The mission of Kinney Drugs is to help people live healthier lives through health and wellness initiatives,” said Dave McClure, President…
Crouse Health has received the American Heart Association’s Get With The Guidelines® – Stroke GoldPlus quality achievement award for its commitment to ensuring stroke patients receive the most appropriate treatment according to nationally recognized, research-based guidelines, ultimately leading to more lives saved and reduced disability. Stroke is the No. 5 cause of death and a…
Crouse Health is the first hospital in Central New York to use the Watchman device, a minimally invasive implant approved by the U.S. Food and Drug Administration as an alternative to long-term blood thinner therapy for patients with atrial fibrillation (AFib), a common heart rhythm disorder. Studies have shown that the Watchman device offers patients…
Over the past decade, the Crouse Institute for Robotic Surgery has become the largest multispecialty robotic surgery program in Central New York, thanks to an experienced team of regionally and nationally recognized physicians and a commitment to using the most advanced, minimally invasive technology available. On Saturday, February 29, we brought a da Vinci surgical…
